That's important, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (the legacy report prediction). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. This was an advancement almost nobody noticed. However it's going to have extensive implications for curing illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech stock 2021). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back maybe substantially before going greater - jeff brown 2020 predictions. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. But that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown biotech pick. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of terrific private companies on the edge of striking the general public markets And I've been working on a new method for you to invest even before these business go public.
This chance has actually been constructing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to book your area totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our usual beat (first lady). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown top stock pick 2021). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing exponential development and developing incredible chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. longtime readers. But despite what many readers might think, this is a trend that's just getting begun. Although the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 2021 stock predictions). Losing two months of production and sales actually impacts how numerous 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million systems is impressive. More significantly, the delays brought on by the pandemic created a lots of pent-up need. Which demand is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G gadgets will be delivered in 2021 - jeff bezos. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 various phases.
In Stage Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Phase Three, 5G services start to be provided (jeff brown biotech stocks). That's when we start to see applications working on 5G networks. Consider things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer. This starts something of a virtuous cycle: The majority of individuals don't really appreciate the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances moving forward will be enormous. Stepping away from 5G, the next important innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a similar idea but with our genetic code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually only 3 companies running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is efficiently a greenfield chance.
There's space for many business to exist in this space. self-driving cars. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can properly forecast the folding of a protein based solely on its amino acid series with 92. 4% precision. That is essential since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced using this innovation. This was among those advancements that almost no one saw. But it's going to have profound ramifications for treating illness. And, of course, there will be a lot of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back perhaps substantially before going higher. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever released was on bitcoin - jeff brown biotech stock pick for 2020. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that preliminary suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. angel investor. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date since February 2021, however we might not separately verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to choose winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an excellent perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares numerous of his finest choices in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully forecasted some of the greatest economic occasions of the previous 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it right each time, however Jeff Brown's precise forecasts have actually made him legions of devoted followers. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent financial research publisher. Brownstone Research study uses several research study services with a wide range of specializations - jeff brown 2021 stock picks.
The business is also associated with Bonner & Partners, another well-respected research study publisher - tech predictions. On its site, Brownstone says its mission is to supply retail investors with professional-grade research: "For too long, the very best investment research has not been readily available to individual investors. It has actually been usually reserved for investment banks, hedge funds, private equity, and high-net-worth clients. tech predictions. The objective of Brownstone Research study is to make that kind of proprietary research available to any financiers seeking to gain an edge in the marketplaces. The objective is easy to provide special and lucrative financial investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. united arab emirates. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. jeff brown predictions for 2021. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: synthetic intelligence and electric cars and trucks. Musk hopes the combination will help him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the automobile market's Holy Grail. As you know, electrical vehicles and self-driving car stocks have been substantial this year, but the Wall Street maker has approved hype without much concrete result. In spite of an extreme boost in competition over the past few years, Brown still thinks Musk has the very best opportunity of putting it all together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Lorry, and it might be the future of transportation. Essentially, this technology would allow you to lease your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the earnings. It sounds outrageous, however it could be closed than you believe.